CS
ORIC icon

Credit Suisse’s Oric Pharmaceuticals ORIC Stock Holding History

Credit Suisse’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17
Closed – – 4207
2022
Q2 		$0 Sell
17
-17,744
-100% -$70.8K ﹤0.01% 4196
2022
Q1 		$94K Sell
17,761
-630
-3% -$5.67K ﹤0.01% 3481
2021
Q4 		$270K Buy
18,391
+2,224
+14% +$34.7K ﹤0.01% 4166
2021
Q3 		$339K Buy
16,167
+3,057
+23% +$62K ﹤0.01% 4036
2021
Q2 		$231K Sell
13,110
-6,226
-32% -$136K ﹤0.01% 4224
2021
Q1 		$473K Sell
19,336
-1,986
-9% -$62.8K ﹤0.01% 3808
2020
Q4 		$722K Buy
+21,322
New +$612K ﹤0.01% 3583

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return